Hiya, I was thinking the same but then with most big firms now firmly endorsing hydrogen and a big focus on plastics decimating the sea bed, it would be a big win for the EU to push a technology that impacts both.
Once you start using plastic to produce hydrogen, you suddenly change it from rubbish to a commodity project. PHE need to start proper conversations with China and India, they need an alternative to coal ASAP, although they have a habit of ignoring IP.
Does anyone know how efficient the PHE process is? Looking at the website, quotes £7-8 kg sale price, just wondering how this equates to current fuel prices?
Also will this be considered a "Green" fuel and not attract fuel duty...
I know hydrogen fuel cells seem the way to go but apparently you can burn using a turbine thereby keeping the temperature lower and avoiding NOx
SP finding some resistance around 5.55p (buy sell margin minimal). Suspect we may see 5p but buyers should then kick in.
Just need that EU fund approval and we will double up but these things take time (they will want significant data on PHE and LINDE will have to throw there weight behind this)
Hi Patxaran, its all about selling more to maximise your position and your agents will want a slice of the pie (they are not in it for fun).
If PHE manage to become number 1 in plastic to hydrogen production they will benefit hugely from recurring revenue...
If PHE are dealing with a few companies to licence their technology, you will need to discount prices as they will expect it. That said once a few plants go live (this is all important) the rest should fall into place.
Remember though where there is money there is competition and this will drive down prices.
You have to remember that if you have a drug to effectively treat Covid19 and save lives, you then have the ability to not vaccinate. On the basis less than 1% of people (vaccinated or not) will need treatment, this would save billions and more importantly the NHS and other healthcare providers could get on with the routine treatments.
It is a frightening thought that over 9% of the UK population need non-covid hospital treatment (6m out of a 66m population)...
Do we think Polygon have enough commitments now on shares in terms of % or do we think they are holding prior to buying more at a reduced price?
I suspect it is the latter but it could be they have elements in the Polygon group that own less than 3% each and therefore enough for a pharma bid...